Brain damage after intrathecal methotrexate.
AUTOR(ES)
Smith, B
RESUMO
Ten brains from leukaemic patients given intrathecal methotrexate and 10 from leukaemic patients without intrathecal therapy have been examined. Three of the methodtrexate treated patients appear to have died from their therapy. The histological changes consisted of destruction of oligodendrocytes, sometimes complete over large areas, and sometimes relatively slight. All the patients who survived long enough after treatment showed severe astrocytosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492077Documentos Relacionados
- Polyglutamation of methotrexate. Is methotrexate a prodrug?
- Folate supplementation and methotrexate.
- Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate.
- Worsening of Felty's syndrome with methotrexate.
- Competitive protein binding assay for methotrexate.
